Global Prostaglandin I2 Market Growth 2025-2031--LP INFORMATION, INC.

Global Prostaglandin I2 Market Growth 2025-2031

Product Code: 1466044

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 89

Delivery Time: 2-3 business days

Global Prostaglandin I2 Market Growth 2025-2031

Product Code: 1466044

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 89

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Prostaglandin I2 market size is predicted to grow from US$ 2853 million in 2025 to US$ 4171 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Prostaglandin I2 (PGI), or prostacyclin, is one of the prostanoids, a group of local hormones that are best known for their roles in mediating inflammation.

The prostaglandin I2 (PGI2) market is driven by its critical role as a potent vasodilator and inhibitor of platelet aggregation, making it an essential therapeutic option for various cardiovascular conditions. PGI2, also known as prostacyclin, is used to treat pulmonary arterial hypertension (PAH), preventing blood clot formation and improving blood flow in affected patients. The increasing prevalence of PAH and the growing awareness of its therapeutic benefits contribute to market growth. Moreover, advancements in pharmaceutical research and biotechnology have led to the development of new formulations and delivery methods for PGI2, further expanding its application in cardiovascular medicine. However, the market also faces challenges, including the high cost of PGI2 therapy, which may limit patient access and affordability. Additionally, the need for continuous infusion in some cases and potential side effects, such as bleeding complications, can pose obstacles for widespread adoption. To succeed in this market, manufacturers must focus on cost-effectiveness, patient-friendly administration methods, and conducting extensive clinical trials to establish the safety and efficacy of PGI2 therapies for various cardiovascular conditions, ensuring its continued use as a critical treatment option.

LP Information, Inc. (LPI) ' newest research report, the “Prostaglandin I2 Industry Forecast” looks at past sales and reviews total world Prostaglandin I2 sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostaglandin I2 sales for 2025 through 2031. With Prostaglandin I2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostaglandin I2 industry.

This Insight Report provides a comprehensive analysis of the global Prostaglandin I2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostaglandin I2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostaglandin I2 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostaglandin I2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostaglandin I2.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostaglandin I2 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Epoprostenol Sodium

    Treprostinil

    Iloprost

    Beraprost Sodium

Segmentation by Application:

    For Injection

    For Oral

    For Inhalation

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    United Therapeutics

    J & J

GSK

    Teva

    Toray

    Tide Pharma

    Bayer AG

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prostaglandin I2 market?

What factors are driving Prostaglandin I2 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prostaglandin I2 market opportunities vary by end market size?

How does Prostaglandin I2 break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Prostaglandin I2 Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Prostaglandin I2 by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Prostaglandin I2 by Country/Region, 2020, 2024 & 2031
    2.2 Prostaglandin I2 Segment by Type
        2.2.1 Epoprostenol Sodium
        2.2.2 Treprostinil
        2.2.3 Iloprost
        2.2.4 Beraprost Sodium
    2.3 Prostaglandin I2 Sales by Type
        2.3.1 Global Prostaglandin I2 Sales Market Share by Type (2020-2025)
        2.3.2 Global Prostaglandin I2 Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Prostaglandin I2 Sale Price by Type (2020-2025)
    2.4 Prostaglandin I2 Segment by Application
        2.4.1 For Injection
        2.4.2 For Oral
        2.4.3 For Inhalation
    2.5 Prostaglandin I2 Sales by Application
        2.5.1 Global Prostaglandin I2 Sale Market Share by Application (2020-2025)
        2.5.2 Global Prostaglandin I2 Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Prostaglandin I2 Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Prostaglandin I2 Breakdown Data by Company
        3.1.1 Global Prostaglandin I2 Annual Sales by Company (2020-2025)
        3.1.2 Global Prostaglandin I2 Sales Market Share by Company (2020-2025)
    3.2 Global Prostaglandin I2 Annual Revenue by Company (2020-2025)
        3.2.1 Global Prostaglandin I2 Revenue by Company (2020-2025)
        3.2.2 Global Prostaglandin I2 Revenue Market Share by Company (2020-2025)
    3.3 Global Prostaglandin I2 Sale Price by Company
    3.4 Key Manufacturers Prostaglandin I2 Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Prostaglandin I2 Product Location Distribution
        3.4.2 Players Prostaglandin I2 Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Prostaglandin I2 by Geographic Region
    4.1 World Historic Prostaglandin I2 Market Size by Geographic Region (2020-2025)
        4.1.1 Global Prostaglandin I2 Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Prostaglandin I2 Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Prostaglandin I2 Market Size by Country/Region (2020-2025)
        4.2.1 Global Prostaglandin I2 Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Prostaglandin I2 Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Prostaglandin I2 Sales Growth
    4.4 APAC Prostaglandin I2 Sales Growth
    4.5 Europe Prostaglandin I2 Sales Growth
    4.6 Middle East & Africa Prostaglandin I2 Sales Growth

5 Americas
    5.1 Americas Prostaglandin I2 Sales by Country
        5.1.1 Americas Prostaglandin I2 Sales by Country (2020-2025)
        5.1.2 Americas Prostaglandin I2 Revenue by Country (2020-2025)
    5.2 Americas Prostaglandin I2 Sales by Type (2020-2025)
    5.3 Americas Prostaglandin I2 Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Prostaglandin I2 Sales by Region
        6.1.1 APAC Prostaglandin I2 Sales by Region (2020-2025)
        6.1.2 APAC Prostaglandin I2 Revenue by Region (2020-2025)
    6.2 APAC Prostaglandin I2 Sales by Type (2020-2025)
    6.3 APAC Prostaglandin I2 Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Prostaglandin I2 by Country
        7.1.1 Europe Prostaglandin I2 Sales by Country (2020-2025)
        7.1.2 Europe Prostaglandin I2 Revenue by Country (2020-2025)
    7.2 Europe Prostaglandin I2 Sales by Type (2020-2025)
    7.3 Europe Prostaglandin I2 Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Prostaglandin I2 by Country
        8.1.1 Middle East & Africa Prostaglandin I2 Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Prostaglandin I2 Revenue by Country (2020-2025)
    8.2 Middle East & Africa Prostaglandin I2 Sales by Type (2020-2025)
    8.3 Middle East & Africa Prostaglandin I2 Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Prostaglandin I2
    10.3 Manufacturing Process Analysis of Prostaglandin I2
    10.4 Industry Chain Structure of Prostaglandin I2

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Prostaglandin I2 Distributors
    11.3 Prostaglandin I2 Customer

12 World Forecast Review for Prostaglandin I2 by Geographic Region
    12.1 Global Prostaglandin I2 Market Size Forecast by Region
        12.1.1 Global Prostaglandin I2 Forecast by Region (2026-2031)
        12.1.2 Global Prostaglandin I2 Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Prostaglandin I2 Forecast by Type (2026-2031)
    12.7 Global Prostaglandin I2 Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 United Therapeutics
        13.1.1 United Therapeutics Company Information
        13.1.2 United Therapeutics Prostaglandin I2 Product Portfolios and Specifications
        13.1.3 United Therapeutics Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 United Therapeutics Main Business Overview
        13.1.5 United Therapeutics Latest Developments
    13.2 J & J
        13.2.1 J & J Company Information
        13.2.2 J & J Prostaglandin I2 Product Portfolios and Specifications
        13.2.3 J & J Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 J & J Main Business Overview
        13.2.5 J & J Latest Developments
    13.3 GSK
        13.3.1 GSK Company Information
        13.3.2 GSK Prostaglandin I2 Product Portfolios and Specifications
        13.3.3 GSK Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 GSK Main Business Overview
        13.3.5 GSK Latest Developments
    13.4 Teva
        13.4.1 Teva Company Information
        13.4.2 Teva Prostaglandin I2 Product Portfolios and Specifications
        13.4.3 Teva Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Teva Main Business Overview
        13.4.5 Teva Latest Developments
    13.5 Toray
        13.5.1 Toray Company Information
        13.5.2 Toray Prostaglandin I2 Product Portfolios and Specifications
        13.5.3 Toray Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Toray Main Business Overview
        13.5.5 Toray Latest Developments
    13.6 Tide Pharma
        13.6.1 Tide Pharma Company Information
        13.6.2 Tide Pharma Prostaglandin I2 Product Portfolios and Specifications
        13.6.3 Tide Pharma Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Tide Pharma Main Business Overview
        13.6.5 Tide Pharma Latest Developments
    13.7 Bayer AG
        13.7.1 Bayer AG Company Information
        13.7.2 Bayer AG Prostaglandin I2 Product Portfolios and Specifications
        13.7.3 Bayer AG Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Bayer AG Main Business Overview
        13.7.5 Bayer AG Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Prostaglandin I2 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Prostaglandin I2 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Epoprostenol Sodium
 Table 4. Major Players of Treprostinil
 Table 5. Major Players of Iloprost
 Table 6. Major Players of Beraprost Sodium
 Table 7. Global Prostaglandin I2 Sales by Type (2020-2025) & (K Units)
 Table 8. Global Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Table 9. Global Prostaglandin I2 Revenue by Type (2020-2025) & ($ million)
 Table 10. Global Prostaglandin I2 Revenue Market Share by Type (2020-2025)
 Table 11. Global Prostaglandin I2 Sale Price by Type (2020-2025) & (US$/Unit)
 Table 12. Global Prostaglandin I2 Sale by Application (2020-2025) & (K Units)
 Table 13. Global Prostaglandin I2 Sale Market Share by Application (2020-2025)
 Table 14. Global Prostaglandin I2 Revenue by Application (2020-2025) & ($ million)
 Table 15. Global Prostaglandin I2 Revenue Market Share by Application (2020-2025)
 Table 16. Global Prostaglandin I2 Sale Price by Application (2020-2025) & (US$/Unit)
 Table 17. Global Prostaglandin I2 Sales by Company (2020-2025) & (K Units)
 Table 18. Global Prostaglandin I2 Sales Market Share by Company (2020-2025)
 Table 19. Global Prostaglandin I2 Revenue by Company (2020-2025) & ($ millions)
 Table 20. Global Prostaglandin I2 Revenue Market Share by Company (2020-2025)
 Table 21. Global Prostaglandin I2 Sale Price by Company (2020-2025) & (US$/Unit)
 Table 22. Key Manufacturers Prostaglandin I2 Producing Area Distribution and Sales Area
 Table 23. Players Prostaglandin I2 Products Offered
 Table 24. Prostaglandin I2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 25. New Products and Potential Entrants
 Table 26. Market M&A Activity & Strategy
 Table 27. Global Prostaglandin I2 Sales by Geographic Region (2020-2025) & (K Units)
 Table 28. Global Prostaglandin I2 Sales Market Share Geographic Region (2020-2025)
 Table 29. Global Prostaglandin I2 Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 30. Global Prostaglandin I2 Revenue Market Share by Geographic Region (2020-2025)
 Table 31. Global Prostaglandin I2 Sales by Country/Region (2020-2025) & (K Units)
 Table 32. Global Prostaglandin I2 Sales Market Share by Country/Region (2020-2025)
 Table 33. Global Prostaglandin I2 Revenue by Country/Region (2020-2025) & ($ millions)
 Table 34. Global Prostaglandin I2 Revenue Market Share by Country/Region (2020-2025)
 Table 35. Americas Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 36. Americas Prostaglandin I2 Sales Market Share by Country (2020-2025)
 Table 37. Americas Prostaglandin I2 Revenue by Country (2020-2025) & ($ millions)
 Table 38. Americas Prostaglandin I2 Sales by Type (2020-2025) & (K Units)
 Table 39. Americas Prostaglandin I2 Sales by Application (2020-2025) & (K Units)
 Table 40. APAC Prostaglandin I2 Sales by Region (2020-2025) & (K Units)
 Table 41. APAC Prostaglandin I2 Sales Market Share by Region (2020-2025)
 Table 42. APAC Prostaglandin I2 Revenue by Region (2020-2025) & ($ millions)
 Table 43. APAC Prostaglandin I2 Sales by Type (2020-2025) & (K Units)
 Table 44. APAC Prostaglandin I2 Sales by Application (2020-2025) & (K Units)
 Table 45. Europe Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 46. Europe Prostaglandin I2 Revenue by Country (2020-2025) & ($ millions)
 Table 47. Europe Prostaglandin I2 Sales by Type (2020-2025) & (K Units)
 Table 48. Europe Prostaglandin I2 Sales by Application (2020-2025) & (K Units)
 Table 49. Middle East & Africa Prostaglandin I2 Sales by Country (2020-2025) & (K Units)
 Table 50. Middle East & Africa Prostaglandin I2 Revenue Market Share by Country (2020-2025)
 Table 51. Middle East & Africa Prostaglandin I2 Sales by Type (2020-2025) & (K Units)
 Table 52. Middle East & Africa Prostaglandin I2 Sales by Application (2020-2025) & (K Units)
 Table 53. Key Market Drivers & Growth Opportunities of Prostaglandin I2
 Table 54. Key Market Challenges & Risks of Prostaglandin I2
 Table 55. Key Industry Trends of Prostaglandin I2
 Table 56. Prostaglandin I2 Raw Material
 Table 57. Key Suppliers of Raw Materials
 Table 58. Prostaglandin I2 Distributors List
 Table 59. Prostaglandin I2 Customer List
 Table 60. Global Prostaglandin I2 Sales Forecast by Region (2026-2031) & (K Units)
 Table 61. Global Prostaglandin I2 Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 62. Americas Prostaglandin I2 Sales Forecast by Country (2026-2031) & (K Units)
 Table 63. Americas Prostaglandin I2 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 64. APAC Prostaglandin I2 Sales Forecast by Region (2026-2031) & (K Units)
 Table 65. APAC Prostaglandin I2 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 66. Europe Prostaglandin I2 Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Europe Prostaglandin I2 Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Middle East & Africa Prostaglandin I2 Sales Forecast by Country (2026-2031) & (K Units)
 Table 69. Middle East & Africa Prostaglandin I2 Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 70. Global Prostaglandin I2 Sales Forecast by Type (2026-2031) & (K Units)
 Table 71. Global Prostaglandin I2 Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 72. Global Prostaglandin I2 Sales Forecast by Application (2026-2031) & (K Units)
 Table 73. Global Prostaglandin I2 Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 74. United Therapeutics Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 75. United Therapeutics Prostaglandin I2 Product Portfolios and Specifications
 Table 76. United Therapeutics Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 77. United Therapeutics Main Business
 Table 78. United Therapeutics Latest Developments
 Table 79. J & J Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 80. J & J Prostaglandin I2 Product Portfolios and Specifications
 Table 81. J & J Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 82. J & J Main Business
 Table 83. J & J Latest Developments
 Table 84. GSK Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 85. GSK Prostaglandin I2 Product Portfolios and Specifications
 Table 86. GSK Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 87. GSK Main Business
 Table 88. GSK Latest Developments
 Table 89. Teva Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 90. Teva Prostaglandin I2 Product Portfolios and Specifications
 Table 91. Teva Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 92. Teva Main Business
 Table 93. Teva Latest Developments
 Table 94. Toray Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 95. Toray Prostaglandin I2 Product Portfolios and Specifications
 Table 96. Toray Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 97. Toray Main Business
 Table 98. Toray Latest Developments
 Table 99. Tide Pharma Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 100. Tide Pharma Prostaglandin I2 Product Portfolios and Specifications
 Table 101. Tide Pharma Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 102. Tide Pharma Main Business
 Table 103. Tide Pharma Latest Developments
 Table 104. Bayer AG Basic Information, Prostaglandin I2 Manufacturing Base, Sales Area and Its Competitors
 Table 105. Bayer AG Prostaglandin I2 Product Portfolios and Specifications
 Table 106. Bayer AG Prostaglandin I2 Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 107. Bayer AG Main Business
 Table 108. Bayer AG Latest Developments


List of Figures
 Figure 1. Picture of Prostaglandin I2
 Figure 2. Prostaglandin I2 Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Prostaglandin I2 Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Prostaglandin I2 Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Prostaglandin I2 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Prostaglandin I2 Sales Market Share by Country/Region (2024)
 Figure 10. Prostaglandin I2 Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Epoprostenol Sodium
 Figure 12. Product Picture of Treprostinil
 Figure 13. Product Picture of Iloprost
 Figure 14. Product Picture of Beraprost Sodium
 Figure 15. Global Prostaglandin I2 Sales Market Share by Type in 2025
 Figure 16. Global Prostaglandin I2 Revenue Market Share by Type (2020-2025)
 Figure 17. Prostaglandin I2 Consumed in For Injection
 Figure 18. Global Prostaglandin I2 Market: For Injection (2020-2025) & (K Units)
 Figure 19. Prostaglandin I2 Consumed in For Oral
 Figure 20. Global Prostaglandin I2 Market: For Oral (2020-2025) & (K Units)
 Figure 21. Prostaglandin I2 Consumed in For Inhalation
 Figure 22. Global Prostaglandin I2 Market: For Inhalation (2020-2025) & (K Units)
 Figure 23. Global Prostaglandin I2 Sale Market Share by Application (2024)
 Figure 24. Global Prostaglandin I2 Revenue Market Share by Application in 2025
 Figure 25. Prostaglandin I2 Sales by Company in 2025 (K Units)
 Figure 26. Global Prostaglandin I2 Sales Market Share by Company in 2025
 Figure 27. Prostaglandin I2 Revenue by Company in 2025 ($ millions)
 Figure 28. Global Prostaglandin I2 Revenue Market Share by Company in 2025
 Figure 29. Global Prostaglandin I2 Sales Market Share by Geographic Region (2020-2025)
 Figure 30. Global Prostaglandin I2 Revenue Market Share by Geographic Region in 2025
 Figure 31. Americas Prostaglandin I2 Sales 2020-2025 (K Units)
 Figure 32. Americas Prostaglandin I2 Revenue 2020-2025 ($ millions)
 Figure 33. APAC Prostaglandin I2 Sales 2020-2025 (K Units)
 Figure 34. APAC Prostaglandin I2 Revenue 2020-2025 ($ millions)
 Figure 35. Europe Prostaglandin I2 Sales 2020-2025 (K Units)
 Figure 36. Europe Prostaglandin I2 Revenue 2020-2025 ($ millions)
 Figure 37. Middle East & Africa Prostaglandin I2 Sales 2020-2025 (K Units)
 Figure 38. Middle East & Africa Prostaglandin I2 Revenue 2020-2025 ($ millions)
 Figure 39. Americas Prostaglandin I2 Sales Market Share by Country in 2025
 Figure 40. Americas Prostaglandin I2 Revenue Market Share by Country (2020-2025)
 Figure 41. Americas Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Figure 42. Americas Prostaglandin I2 Sales Market Share by Application (2020-2025)
 Figure 43. United States Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 44. Canada Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 45. Mexico Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 46. Brazil Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 47. APAC Prostaglandin I2 Sales Market Share by Region in 2025
 Figure 48. APAC Prostaglandin I2 Revenue Market Share by Region (2020-2025)
 Figure 49. APAC Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Figure 50. APAC Prostaglandin I2 Sales Market Share by Application (2020-2025)
 Figure 51. China Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 52. Japan Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 53. South Korea Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 54. Southeast Asia Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 55. India Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 56. Australia Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 57. China Taiwan Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 58. Europe Prostaglandin I2 Sales Market Share by Country in 2025
 Figure 59. Europe Prostaglandin I2 Revenue Market Share by Country (2020-2025)
 Figure 60. Europe Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Figure 61. Europe Prostaglandin I2 Sales Market Share by Application (2020-2025)
 Figure 62. Germany Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 63. France Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 64. UK Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 65. Italy Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 66. Russia Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 67. Middle East & Africa Prostaglandin I2 Sales Market Share by Country (2020-2025)
 Figure 68. Middle East & Africa Prostaglandin I2 Sales Market Share by Type (2020-2025)
 Figure 69. Middle East & Africa Prostaglandin I2 Sales Market Share by Application (2020-2025)
 Figure 70. Egypt Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 71. South Africa Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 72. Israel Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 73. Turkey Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 74. GCC Countries Prostaglandin I2 Revenue Growth 2020-2025 ($ millions)
 Figure 75. Manufacturing Cost Structure Analysis of Prostaglandin I2 in 2025
 Figure 76. Manufacturing Process Analysis of Prostaglandin I2
 Figure 77. Industry Chain Structure of Prostaglandin I2
 Figure 78. Channels of Distribution
 Figure 79. Global Prostaglandin I2 Sales Market Forecast by Region (2026-2031)
 Figure 80. Global Prostaglandin I2 Revenue Market Share Forecast by Region (2026-2031)
 Figure 81. Global Prostaglandin I2 Sales Market Share Forecast by Type (2026-2031)
 Figure 82. Global Prostaglandin I2 Revenue Market Share Forecast by Type (2026-2031)
 Figure 83. Global Prostaglandin I2 Sales Market Share Forecast by Application (2026-2031)
 Figure 84. Global Prostaglandin I2 Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

United Therapeutics

J & J

GSK

Teva

Toray

Tide Pharma

Bayer AG

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff